GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Churchill Capital Corp VII (NAS:CVIIU) » Definitions » Research & Development

Churchill Capital VII (Churchill Capital VII) Research & Development : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Churchill Capital VII Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Churchill Capital VII's Research & Development for the three months ended in Mar. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Churchill Capital VII Research & Development Historical Data

The historical data trend for Churchill Capital VII's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Churchill Capital VII Research & Development Chart

Churchill Capital VII Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
- - - -

Churchill Capital VII Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Churchill Capital VII Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Churchill Capital VII  (NAS:CVIIU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Churchill Capital VII Research & Development Related Terms

Thank you for viewing the detailed overview of Churchill Capital VII's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Churchill Capital VII (Churchill Capital VII) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Churchill Capital Corp VII (NAS:CVIIU) » Definitions » Research & Development
Comparable Companies
SCRM AAC GHIX ALCC AACT DWAC SAGA HCVI TRTL CCVI PBAJ SVMB LSE:ADMR SLAM NETD CXAC NFNT APGB KCGI CNDA
Traded in Other Exchanges
CVII:USA
Address
640 Fifth Avenue, 12th Floor, New York, NY, USA, 10019
Website
https://vii.churchillcapitalcorp.com
Churchill Capital Corp VII is a blank check company.
Executives
Atlas Merchant Capital Llc 10 percent owner 477 MADISON AVENUE, 22ND FLOOR, NEW YORK NY 10022
Magnetar Financial Llc 10 percent owner 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201
Magnetar Capital Partners Lp 10 percent owner 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201
Supernova Management Llc 10 percent owner 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201
David J. Snyderman 10 percent owner C/O MAGNETAR FINANCIAL LLC, 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201
Alan Schrager director C/O OHA INVESTMENT CORPORATION, 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Stephen Anthony Murphy director 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Andrew Frankle director 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Malcolm Stephen Mcdermid director C/O CTC MY CFO, P.O. BOX 10195, DEPT. 1173, PALO ALTO CA 94303
Churchill Sponsor Vii Llc 10 percent owner 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Lee Jay Taragin officer: Chief Financial Officer 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Bonnie Jonas director 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Michael Stuart Klein director, 10 percent owner, officer: See Remarks C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017
M. Klein Associates, Inc. 10 percent owner 640 FIFTH AVENUE, 12TH FLOOR, NEW YORK NY 10019
Glenn R August director C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036